BIIB
Price
$253.84
Change
+$12.86 (+5.34%)
Updated
Oct 22 closing price
Capitalization
37.51B
6 days until earnings call
Intraday BUY SELL Signals
MVAL
Price
$38.27
Change
-$0.22 (-0.57%)
Updated
Oct 19 closing price
Net Assets
1.93M
Intraday BUY SELL Signals
Interact to see
Advertisement

BIIB vs MVAL

BIIB vs MVAL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BIIB vs. MVAL commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Hold and MVAL is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BIIB with price predictions
Oct 22, 2026

BIIB's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for BIIB turned positive on October 13, 2026. Looking at past instances where BIIB's MACD turned positive, the stock continued to rise in 39 of 60 cases over the following month. The odds of a continued upward trend are 65%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on BIIB as a result. In 50 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.

Following a +4.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where BIIB advanced for three days, in 166 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.

The Aroon Indicator entered an Uptrend today. In 122 of 197 cases where BIIB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIIB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.

BIIB broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 6 (best 1 - 100 worst), indicating outstanding price growth. BIIB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.990) is normal, around the industry mean (-3.019). P/E Ratio (44.690) is within average values for comparable stocks, (21.251). Projected Growth (PEG Ratio) (2.357) is also within normal values, averaging (5.738). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (3.189) is also within normal values, averaging (4.033).

The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIIB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock worse than average.

A.I.Advisor
a Summary for MVAL with price predictions
Oct 22, 2026

MVAL in upward trend: price rose above 50-day moving average on October 16, 2026

MVAL moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend. In 11 of 13 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MVAL as a result. In 30 of 41 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for MVAL just turned positive on October 07, 2026. Looking at past instances where MVAL's MACD turned positive, the stock continued to rise in 17 of 23 cases over the following month. The odds of a continued upward trend are 74%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MVAL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.

MVAL broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MVAL entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

FUNDAMENTALS RATINGS
BIIB: Fundamental Ratings
BIIB
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
84
PRICE GROWTH RATING
1..100
6
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIIBMVAL
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
62%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
59%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
68%
Bearish Trend 21 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
56%
Aroon
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
36%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (BIIB: $253.84)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 2 FA rating(s) are green while .

  • BIIB’s FA Score: 2 green, 3 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 4 TA indicator(s) are bullish.

  • BIIB’s TA Score: 4 bullish, 4 bearish.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а +7.86% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.32%. For the same industry, the average monthly price growth was -5.34%, and the average quarterly price growth was +5.08%.

Reported Earning Dates

BIIB is expected to report earnings on Oct 28, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+0.32% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
BIIB
Daily Signal:
Gain/Loss:
MVAL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

MVAL and

Correlation & Price change

A.I.dvisor tells us that MVAL and ROP have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MVAL and ROP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MVAL
1D Price
Change %
MVAL100%
N/A
ROP - MVAL
13%
Poorly correlated
+9.73%
BX - MVAL
13%
Poorly correlated
+8.38%
BIIB - MVAL
11%
Poorly correlated
+5.34%
A - MVAL
10%
Poorly correlated
-2.17%
BR - MVAL
10%
Poorly correlated
+4.39%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JELD1.420.14
+10.94%
JELD-WEN Holding
CLBT11.790.29
+2.52%
Cellebrite DI Ltd
IBEX46.940.03
+0.06%
IBEX Limited
AS28.98-0.60
-2.03%
Amer Sports
CENN2.29-0.16
-6.53%
Cenntro Inc.